Standard Bio raises growth capital

  • 🇳🇴 MarchFirst

Explore Deal Preview

  • October 29, 2024
🇳🇴
  • Energy & Cleantech
Standard BIO
Standard Bio raises growth capital
Deal Crux
N/A

Learn More About This Deal:

  • EMEA
  • 🇳🇴 Norway
  • Energy & Cleantech
  • Equity
  • 2024
MarchFirst acted as advisor to Standard Bio, a Norwegian company converting agricultural and forestry bio-waste into carbon-storing biocarbon products, on a capital raise.
MarchFirst [Logo Mini]
Member Firm
🇳🇴

MarchFirst

Based in Norway, MarchFirst is an independent and partner-owned M&A boutique focusing on Nordic SME’s working with all sectors and all asset classes. Our European network consists of Private Equity, key industrial names and High Net Worth Individuals.
  • www.marchfirst.no
  • aa@marchfirst.no
Energy & Cleantech

Other Deals in this Sector

Our global partners gain competitive advantages that transform their ability to win and close international deals across 14 core sectors.

All Deals
🇩🇰
  • Energy & Cleantech
Kvasir Technologies secures EUR 10m growth financing in the first close of Series A
  • Explore this Deal
🇮🇳
  • Energy & Cleantech
Successful IPO of Avana Electrosystems on National Stock Exchange
  • Explore this Deal
🇺🇸
  • Energy & Cleantech
Turntide Technologies engaged Bengur Bryan to prepare a debt CIM and strategic financing analysis to support its capital structure planning
  • Explore this Deal
🇳🇴 MarchFirst

Other Deals by Member Firm

Advisiom partner firms share deep industry knowledge, with partner led execution on cross-border deals, globally.

All Deals
🇳🇴
  • Consumer & Retail
Alpha Brands AS sold to Viva Wine Group AB
  • Explore this Deal
🇳🇴
  • Financial Services
Kvam Rekneskapskontor sold to its Management Team
  • Explore this Deal
🇩🇰
  • Industrials
Textilia Group acquired Sentralvaskeriet for Østlandet AS
  • Explore this Deal

“Our partner firms are elite and carefully vetted boutique M&A firms who share our values: integrity, entrepreneurship and excellence.”

Amanda Simmons, Msc
Founder & CEO
Schedule a Meeting

2026 Cross-Border M&A Advisory That Delivers Results

  • 2026